Menu
/REGISTER
PPB
Montecito
ROAM
Loading...
You are here:  Home  >  Technology  -  Page 49

Santa Barbara Web Design
Latest

Oak Therapeutics touts study results for dissolvable strips

By   /  Thursday, October 5th, 2017  /  Health Care, Latest news, Technology  /  Comments Off on Oak Therapeutics touts study results for dissolvable strips

Oak Therapeutics, based in Oxnard, announced that it completed a study of the use of its dissolvable strips to administer an anti-tuberculosis treatment orally. A 300 milligram dose of isoniazid on the dissolvable strips given to canines entered the bloodstream at a statistically similar rate to commercial tablets, the study found. The company, a subsidiary Read More →

Read More →
Latest

Amgen lawsuit over cholesterol drug will get new trial

By   /  Thursday, October 5th, 2017  /  Health Care, Latest news, Technology  /  Comments Off on Amgen lawsuit over cholesterol drug will get new trial

An Amgen lawsuit against a competing cholesterol drug will get a new trial but sales of the drug will be allowed in the U.S. until a decision is rendered. A federal court of appeals judge threw out a ban on the sale of Praluent, manufactured by New York-based Regeneron Pharmaceuticals and French biotech company Sanofi Read More →

Read More →
Latest

Mannkind stock soars over new label info for Afrezza

By   /  Monday, October 2nd, 2017  /  Earnings, Health Care, Latest news, Technology, Tri-County Public Companies  /  Comments Off on Mannkind stock soars over new label info for Afrezza

Westlake Village biotech company Mannkind received approval to update the prescribing information for its inhalable insulin product, Afrezza, making it easier to market to customers. The new label information clarifies starting and adjusting mealtime dosages, as well as initial and peak effects, and helps the company avoid confusing language, CEO Michael Castagna said in a Read More →

Read More →
Latest

GeoLinks using Silicon Valley-style office to attract employees

By   /  Friday, September 29th, 2017  /  Latest news, Technology, West Ventura County  /  Comments Off on GeoLinks using Silicon Valley-style office to attract employees

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Read More →
Latest

UCSB researchers get $9 million to develop new brain imaging

By   /  Friday, September 29th, 2017  /  Education, Latest news, Technology  /  Comments Off on UCSB researchers get $9 million to develop new brain imaging

UC Santa Barbara researchers received $9 million to further their efforts to get a better view of the human brain. The National Science Foundation awarded the funding to the Next Generation Multiphoton Neuroimaging Consortium project, or NEMONIC, which includes UCSB researchers John Bowers, Michael Goard and Luke Theogarajan among its team of neuroscientists, electrical engineers, Read More →

Read More →
Latest

CalAmp reports revenue decline but net income up

By   /  Thursday, September 28th, 2017  /  Earnings, Latest news, Technology, Tri-County Public Companies, West Ventura County  /  Comments Off on CalAmp reports revenue decline but net income up

Information technology company CalAmp reported on Sept. 28 a slight drop in revenue for its second quarter but a dramatic increase in net income, bringing in $12.2 million, or 34 cents per share. The company, which has operations in Oxnard, brought in $89.8 million during the quarter, down slightly from $90.5 million in the second Read More →

Read More →
Latest

Amgen settles with AbbVie over Humira biosimilar

By   /  Thursday, September 28th, 2017  /  East Ventura County, Health Care, Latest news, Technology  /  Comments Off on Amgen settles with AbbVie over Humira biosimilar

Thousand Oaks biopharmaceutical giant Amgen announced Sept. 28 that it had reached a settlement with Chicago-based competitor AbbVie, which had sued to block Amgen’s Humira biosimilar Amjevita. The rheumatoid arthritis and inflammation treatment received U.S. Food and Drug Administration approval in September of 2016, but sales were blocked when AbbVie filed a patent infringement claim Read More →

Read More →